Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-02

Clinical Trial Update: Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral versus intravenous hydration to prevent contrast-induced nephropathy in patients with renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: David Garcia Cinca | Conditions: Renal Insufficiency | Phase 3 | Status: COMPLETED